These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31559013)

  • 1. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system.
    Iwasaki M; Akiba Y; Kaunitz JD
    F1000Res; 2019; 8():. PubMed ID: 31559013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
    Fung C; Unterweger P; Parry LJ; Bornstein JC; Foong JP
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G748-58. PubMed ID: 24578344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease.
    Lelievre V; Favrais G; Abad C; Adle-Biassette H; Lu Y; Germano PM; Cheung-Lau G; Pisegna JR; Gressens P; Lawson G; Waschek JA
    Peptides; 2007 Sep; 28(9):1688-99. PubMed ID: 17606312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries.
    Grant S; Lutz EM; McPhaden AR; Wadsworth RM
    J Cereb Blood Flow Metab; 2006 Jan; 26(1):58-67. PubMed ID: 15959462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy.
    Dvoráková MC; Pfeil U; Kuncová J; Svíglerová J; Galvis G; Krasteva G; König P; Grau V; Slavíková J; Kummer W
    Cell Tissue Res; 2006 Mar; 323(3):383-93. PubMed ID: 16344947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.
    Martínez C; Juarranz Y; Gutiérrez-Cañas I; Carrión M; Pérez-García S; Villanueva-Romero R; Castro D; Lamana A; Mellado M; González-Álvaro I; Gomariz RP
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
    Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation.
    St Hilaire RC; Murthy SN; Kadowitz PJ; Jeter JR
    Peptides; 2010 Aug; 31(8):1517-22. PubMed ID: 20452385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.
    Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B
    J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide (VIP) stimulates cortisol secretion from the H295 human adrenocortical tumour cell line via VPAC1 receptors.
    Nicol MR; Cobb VJ; Williams BC; Morley SD; Walker SW; Mason JI
    J Mol Endocrinol; 2004 Jun; 32(3):869-77. PubMed ID: 15171718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).
    Huang MC; Miller AL; Wang W; Kong Y; Paul S; Goetzl EJ
    J Immunol; 2006 Jun; 176(11):6640-6. PubMed ID: 16709822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart.
    Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ
    Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
    Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.